• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill. A new laboratory-based surveillance system (Respiratory DataMart System) for influenza and other respiratory viruses in England: result

Giuseppe

Emeritus
[Source: Eurosurveillance, full page: (LINK). Abstract, edited.]


Eurosurveillance, Volume 19, Issue 3, 23 January 2014

Surveillance and outbreak reports

A new laboratory-based surveillance system (Respiratory DataMart System) for influenza and other respiratory viruses in England: results and experience from 2009 to 2012

H Zhao<SUP>1</SUP>, H Green<SUP>1</SUP>, A Lackenby<SUP>2</SUP>, M Donati<SUP>3</SUP>, J Ellis<SUP>2</SUP>, C Thompson<SUP>2</SUP>, A Bermingham<SUP>2</SUP>, J Field<SUP>1</SUP>, P SebastianPillai<SUP>2</SUP>, M Zambon<SUP>2</SUP>, J M Watson<SUP>1</SUP>, R Pebody <SUP>1</SUP>
<SUP></SUP>
<SUP>1</SUP>Respiratory Diseases Department, Public Health England (PHE), Colindale, London, United Kingdom ? 2 Respiratory Virus Unit, Virus Reference Department, Public Health England( PHE) Microbiology Services, London, United Kingdom - 3 Bristol Public Health Laboratory, Public Health England (PHE), Bristol, United Kingdom
_____

Citation style for this article: Zhao H, Green H, Lackenby A, Donati M, Ellis J, Thompson C, Bermingham A, Field J, SebastianPillai P, Zambon M, Watson JM, Pebody R. A new laboratory-based surveillance system (Respiratory DataMart System) for influenza and other respiratory viruses in England: results and experience from 2009 to 2012 . Euro Surveill. 2014;19(3):pii=20680. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20680
Date of submission: 19 October 2012

_____

During the 2009 influenza A(H1N1) pandemic, a new laboratory-based virological sentinel surveillance system, the Respiratory DataMart System (RDMS), was established in a network of 14 Health Protection Agency (now Public Health England (PHE)) and National Health Service (NHS) laboratories in England. Laboratory results (both positive and negative) were systematically collected from all routinely tested clinical respiratory samples for a range of respiratory viruses including influenza, respiratory syncytial virus (RSV), rhinovirus, parainfluenza virus, adenovirus and human metapneumovirus (hMPV). The RDMS also monitored the occurrence of antiviral resistance of influenza viruses. Data from the RDMS for the 2009?2012 period showed that the 2009 pandemic influenza virus caused three waves of activity with different intensities during the pandemic and post pandemic periods. Peaks in influenza A(H1N1)pdm09 positivity (defined as number of positive samples per total number of samples tested) were seen in summer and autumn in 2009, with slightly higher peak positivity observed in the first post-pandemic season in 2010/2011. The influenza A(H1N1)pdm09 virus strain almost completely disappeared in the second post-pandemic season in 2011/2012. The RDMS findings are consistent with other existing community-based virological and clinical surveillance systems. With a large sample size, this new system provides a robust supplementary mechanism, through the collection of routinely available laboratory data at minimum extra cost, to monitor influenza as well as other respiratory virus activity. A near real-time, daily reporting mechanism in the RDMS was established during the London 2012 Olympic and Paralympic Games. Furthermore, this system can be quickly adapted and used to monitor future influenza pandemics and other major outbreaks of respiratory infectious disease, including novel pathogens.


-
-------
 
Back
Top Bottom